Infection profile of immune-modulatory drugs used in autoimmune diseases: analysis of summary of product characteristic data
Objective Serious infection remains a concern when prescribing immune-modulatory drugs for immune-mediated inflammatory diseases. The ‘summary of product characteristics’ (SmPCs) provide information on adverse events for example, infections, from clinical trials and postmarketing pharmacovigilance.T...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-11-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/8/2/e002621.full |